Health ❯Healthcare ❯Patient Safety

Adverse Events

Patient Safety Pharmaceuticals Drug Development Gene Therapy FDA Drug Side Effects Public Policy Pharmaceutical Stocks FDA Regulations Medical Studies

FDA Halts Rocket’s RP-A501 Gene Therapy for Danon Disease After Patient’s Death

The hold follows a fatal capillary leak syndrome event prompting scrutiny of a newly introduced immune suppression agent

Abortion Pill Study Fuels Debate Over Safety and Access

First Death Reported from Sarepta's Duchenne Gene Therapy Raises Safety Concerns